Literature DB >> 24019057

Development of auditory event-related potentials in infants prenatally exposed to methadone.

Jonathan A Paul1, Beth A Logan, Ramesh Krishnan, Nicole A Heller, Deborah G Morrison, Ursula A Pritham, Paul W Tisher, Marcia Troese, Mark S Brown, Marie J Hayes.   

Abstract

Developmental features of the P2 auditory ERP in a change detection paradigm were examined in infants prenatally exposed to methadone. Opiate dependent pregnant women maintained on methadone replacement therapy were recruited during pregnancy (N = 60). Current and historical alcohol and substance use, SES, and psychiatric status were assessed with a maternal interview during the third trimester. Medical records were used to collect information regarding maternal medications, monthly urinalysis, and breathalyzer to confirm comorbid drug and alcohol exposures. Between birth and 4 months infant ERP change detection performance was evaluated on one occasion with the oddball paradigm (.2 probability oddball) using pure-tone stimuli (standard = 1 kHz and oddball = 2 kHz frequency) at midline electrode sites, Fz, Cz, Pz. Infant groups were examined in the following developmental windows: 4-15, 16-32, or 33-120 days PNA. Older groups showed increased P2 amplitude at Fz and effective change detection performance at P2 not seen in the newborn group. Developmental maturation of amplitude and stimulus discrimination for P2 has been reported in developing infants at all of the ages tested and data reported here in the older infants are consistent with typical development. However, it has been previously reported that the P2 amplitude difference is detectable in neonates; therefore, absence of a difference in P2 amplitude between stimuli in the 4-15 days group may represent impaired ERP performance by neonatal abstinence syndrome or prenatal methadone exposure.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  MMN; auditory event-related potential; infant P2; methadone; mismatch negativity; neurocognitive development; prenatal methadone exposure

Mesh:

Substances:

Year:  2013        PMID: 24019057     DOI: 10.1002/dev.21160

Source DB:  PubMed          Journal:  Dev Psychobiol        ISSN: 0012-1630            Impact factor:   3.038


  8 in total

Review 1.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

2.  Association between prenatal opioid exposure, neonatal opioid withdrawal syndrome, and neurodevelopmental and behavioral outcomes at 5-8 months of age.

Authors:  Ludmila N Bakhireva; Bradley D Holbrook; Shikhar Shrestha; Yuridia Leyva; Malia Ashley; Sandra Cano; Jean Lowe; Julia M Stephen; Lawrence Leeman
Journal:  Early Hum Dev       Date:  2018-12-13       Impact factor: 2.079

Review 3.  Developmental opioid exposures: Neurobiological underpinnings, behavioral impacts, and policy implications.

Authors:  Samantha S Goldfarb; Gregg D Stanwood; Heather A Flynn; Devon L Graham
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-20

Review 4.  Prenatal drug exposure from infancy through emerging adulthood: Results from neuroimaging.

Authors:  Kristen P Morie; Michael J Crowley; Linda C Mayes; Marc N Potenza
Journal:  Drug Alcohol Depend       Date:  2019-02-28       Impact factor: 4.492

5.  Use and Misuse of Opioids in Maine: Results From Pharmacists, the Prescription Monitoring, and the Diversion Alert Programs.

Authors:  Brian J Piper; Clare E Desrosiers; John W Lipovsky; Matthew A Rodney; Robert P Baker; Kenneth L McCall; Stephanie D Nichols; Sarah L Martin
Journal:  J Stud Alcohol Drugs       Date:  2016-07       Impact factor: 2.582

6.  Perinatal Opioid Exposure Results in Persistent Hypoconnectivity of Excitatory Circuits and Reduced Activity Correlations in Mouse Primary Auditory Cortex.

Authors:  Binghan Xue; Jason B Alipio; Joseph P Y Kao; Patrick O Kanold
Journal:  J Neurosci       Date:  2022-03-24       Impact factor: 6.709

7.  Enduring consequences of perinatal fentanyl exposure in mice.

Authors:  Jason B Alipio; Adam T Brockett; Megan E Fox; Stephen S Tennyson; Coreylyn A deBettencourt; Dina El-Metwally; Nikolas A Francis; Patrick O Kanold; Mary Kay Lobo; Matthew R Roesch; Asaf Keller
Journal:  Addict Biol       Date:  2020-03-18       Impact factor: 4.280

8.  A core outcome set for neonatal abstinence syndrome: study protocol for a systematic review, parent interviews and a Delphi survey.

Authors:  Lauren E Kelly; Lauren M Jansson; Wendy Moulsdale; Jodi Pereira; Sarah Simpson; Astrid Guttman; Karel Allegaert; Lisa Askie; Henry Roukema; Thierry Lacaze; Jonathan M Davis; Loretta Finnegan; Paula Williamson; Martin Offringa
Journal:  Trials       Date:  2016-11-08       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.